Keith S. Reisinger

8.0k total citations · 1 hit paper
108 papers, 6.0k citations indexed

About

Keith S. Reisinger is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Keith S. Reisinger has authored 108 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Epidemiology, 32 papers in Microbiology and 20 papers in Infectious Diseases. Recurrent topics in Keith S. Reisinger's work include Bacterial Infections and Vaccines (32 papers), Pneumonia and Respiratory Infections (32 papers) and Influenza Virus Research Studies (22 papers). Keith S. Reisinger is often cited by papers focused on Bacterial Infections and Vaccines (32 papers), Pneumonia and Respiratory Infections (32 papers) and Influenza Virus Research Studies (22 papers). Keith S. Reisinger collaborates with scholars based in United States, United Kingdom and Japan. Keith S. Reisinger's co-authors include Mark M. Blatter, Stan L. Block, Frederick G. Hayden, David I. Bernstein, Regina Dutkowski, Edward Rothstein, Nancy L. Young, David Ipe, Penelope Ward and Roger Mills and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PEDIATRICS.

In The Last Decade

Keith S. Reisinger

107 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral oseltamivir treatment of influenza in children

2001 541 citations Richard J. Whitley, Frederick G. Hayden et al. The Pediatric Infectious Disease Journal profile →

Peers

Countries citing papers authored by Keith S. Reisinger

Since Specialization

Citations

This map shows the geographic impact of Keith S. Reisinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith S. Reisinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith S. Reisinger more than expected).

Fields of papers citing papers by Keith S. Reisinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith S. Reisinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith S. Reisinger. The network helps show where Keith S. Reisinger may publish in the future.

Co-authorship network of co-authors of Keith S. Reisinger

This figure shows the co-authorship network connecting the top 25 collaborators of Keith S. Reisinger. A scholar is included among the top collaborators of Keith S. Reisinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith S. Reisinger. Keith S. Reisinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibody Persistence and Booster Response of a Quadrivalent Meningococcal Conjugate Vaccine in Adolescents 2014 ·The Journal of Pediatrics ·Roger Baxter, Keith S. Reisinger, S. Block, Allen Izu, Tatjana Odrljin, Peter Dull	33
2	Antibody Persistence After Primary and Booster Doses of a Quadrivalent Meningococcal Conjugate Vaccine in Adolescents 2014 ·The Pediatric Infectious Disease Journal ·Roger Baxter, Keith S. Reisinger, S. Block, Sandra Percell, Tatjana Odrljin, Peter Dull, Igor Smolenov	26
3	Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children 2013 ·The Journal of Infectious Diseases ·Joanne M. Langley, (unknown), Archana Chatterjee, Scott A. Halperin, Shelly McNeil, Keith S. Reisinger, Naresh Aggarwal, Li‐Min Huang, Ching‐Tien Peng, José García-Sicilia, Ignacio Salamanca de la Cueva, Fernando Cabañas, (unknown), M Weber, (unknown), Vijayalakshmi Chandrasekaran, Walthère Dewé, Aixue Liu, Bruce L. Innis, Varsha Jain	51
4	Safety and tolerability of zoster vaccine in adults ≥60 years old 2011 ·Human Vaccines ·Alexander V. Murray, Keith S. Reisinger, Boris Kerzner, Jon E. Stek, (unknown), Jin Xu, (unknown), Ivan S. F. Chan, Paula W. Annunziato, Janie Parrino	32
5	Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6–59 months 2009 ·Vaccine ·James C. King, Manon Cox, Keith S. Reisinger, James Hedrick, Irene Graham, P. Patriarca	58
6	A Randomized Trial to Determine the Tolerability and Immunogenicity of a Quadrivalent Meningococcal Glycoconjugate Vaccine in Healthy Adolescents 2009 ·The Pediatric Infectious Disease Journal ·Lisa A. Jackson, Robert M. Jacobson, Keith S. Reisinger, Alessandra Anemona, Lisa Danzig, Peter Dull	61
7	Safety and Persistent Immunogenicity of a Quadrivalent Human Papillomavirus Types 6, 11, 16, 18 L1 Virus-Like Particle Vaccine in Preadolescents and Adolescents 2007 ·The Pediatric Infectious Disease Journal ·Keith S. Reisinger, Stan L. Block, Eduardo Lazcano‐Ponce, Rudiwilai Samakoses, Mark T. Esser, (unknown), (unknown), Katherine Giacoletti, Heather L. Sings, (unknown), Frances B. Alvarez, Eliav Barr	225
8	Safety, Tolerability and Immunogenicity of VAQTA Given Concomitantly versus Nonconcomitantly With Other Pediatric Vaccines in Healthy 12-Month-Old Children 2006 ·The Pediatric Infectious Disease Journal ·(unknown), Jacqueline Gress, Alan Werzberger, Keith S. Reisinger, Emmanuel B. Walter, Hassan Lakkis, (unknown), (unknown), Barbara J. Kuter	9
9	Dose-Response Study of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy Children 2005 ·The Pediatric Infectious Disease Journal ·Henry R. Shinefield, Wendy R. Williams, Colin D. Marchant, Keith S. Reisinger, (unknown), H. Cody Meissner, (unknown), Stephanie O. Klopfer, F. Schödel, Barbara J. Kuter	32
10	Measuring Antibody Responses to a Live Attenuated Influenza Vaccine in Children 2004 ·The Pediatric Infectious Disease Journal ·(unknown), Kutubuddin Mahmood, Lopa Adhikary, Marilyn J. August, Julie Cordova, Iksung Cho, George Kemble, Keith S. Reisinger, Robert Walker, Paul M. Mendelman	43
11	Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination 2002 ·The Pediatric Infectious Disease Journal ·Michael E. Pichichero, Mark M. Blatter, Keith S. Reisinger, Christopher J. Harrison, Candice E. Johnson, Mark C. Steinhoff, Shelly Senders, Edward Rothstein, Paul Willems, Barbara J. Howe	41
12	Oral oseltamivir treatment of influenza in children breakdown → 2001 ·The Pediatric Infectious Disease Journal ·Richard J. Whitley, Frederick G. Hayden, Keith S. Reisinger, Nancy L. Young, Regina Dutkowski, David Ipe, Roger Mills, Penelope Ward	541
13	An acellular pertussis vaccine in healthy adults: safety and immunogenicity 1999 ·Vaccine ·Edward Rothstein, Edwin L. Anderson, Michael D. Decker, Gregory A. Poland, Keith S. Reisinger, Mark M. Blatter, Robert M. Jacobson, ChrisAnna M. Mink, Daniel Gennevois, Allen Izu, Faruk Sinangil, Andria Langenberg	22
14	Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type b/hepatitis B vaccine 1997 ·The Pediatric Infectious Disease Journal ·Neal A. Halsey, Mark M. Blatter, (unknown), M. L. Thoms, Field F. Willingham, (unknown), (unknown), (unknown), Keith S. Reisinger, (unknown)	24
15	Inactivated hepatitis A vaccine in childhood: implications for disease control 1993 ·Vaccine ·DavidR. Nalin, Liliana Brown, Barbara J. Kuter, (unknown), (unknown), Alan Werzberger, Mathuram Santosham, S. Block, Keith S. Reisinger, Barbara Watson, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	14
16	Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17− to 24-month-old children 1992 ·The Pediatric Infectious Disease Journal ·Mary P. Glodé, (unknown), Keith S. Reisinger, Mark M. Blatter, (unknown), Barbara Watson, (unknown), Basim I. Asmar, Michael J. Berry, (unknown), (unknown), Jill Hackell, (unknown), (unknown)	22
17	Cefixime vs. cefaclor in the treatment of acute otitis media in infants and children 1987 ·The Pediatric Infectious Disease Journal ·Margaret A. Kenna, Charles D. Bluestone, Patricia A. Fall, (unknown), Marcia Kurs‐Lasky, (unknown), Mark M. Blatter, Keith S. Reisinger	34
18	Wall Socket Electrical Burns: Relevance to Health Education? 1980 ·PEDIATRICS ·(unknown), Keith S. Reisinger	12
19	Inaccuracy of the Clinitemp skin thermometer. 1979 ·PubMed ·Keith S. Reisinger, (unknown), (unknown)	23
20	Effectiveness of Aggressive Follow-up on Navajo Infant Health and Medical Care Use 1974 ·PEDIATRICS ·Kenneth D. Rogers, (unknown), (unknown), Keith S. Reisinger	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact